Search results
Results from the WOW.Com Content Network
A page addressing workplace diversity at the CDC’s National Center for HIV, Viral Hepatitis, STD and Tuberculosis Prevention, of which the HIV department is a division, for example, has been ...
The U.S. Centers for Disease Control and Prevention and other federal health agencies on Friday took down webpages with information on HIV statistics and other data to comply with Trump ...
Government agency webpages about HIV, LGBTQ+ people and multiple other public health topics are down Friday evening due to President Donald Trump's executive orders aimed at gender ideology and ...
A demonstrator waves a placard using the "Silence=Death" slogan during a 2017 event in New York City.Activist groups focused on HIV/AIDS in the United States initially drew their numbers from the bisexual, lesbian, and male homosexual communities as a whole, with socio-political campaigns including culturally active patients who were struggling with their healthcare themselves.
Around January 31, 2025, several CDC websites, pages, and datasets related to HIV and STI prevention, LGBT and youth health became unavailable for viewing after the agency was ordered to comply with Donald Trump's executive order to remove all material of "diversity, equity, and inclusion" and "gender identity".
Ready, Set, PrEP is a program of the U.S. Department of Health and Human Services (HHS) that provides free access to the HIV prevention medication PrEP for thousands of qualifying individuals. The program is a key component of Ending the HIV Epidemic: A Plan for America (EHE) initiative to expand access to PrEP and reduce new HIV diagnoses in ...
The campaign seeks to spread the scientific evidence that undetectable means untransmittable. Since the beginning of the epidemic, perceptions and management of HIV infection have gone through many stages; from assuming the infectiousness, then discovering the routes of transmission (blood, sexual fluids, and breastfeeding), to prevention methods (education, condoms, PrEP, and PEP) and various ...
Gilead Sciences and the U.S. government have settled a billion-dollar patent dispute over Gilead's HIV prevention drugs Truvada and Descovy, according to a Wednesday filing in Delaware federal court.